LIFECORE BIOMEDICAL, INC. Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent
LIFECORE BIOMEDICAL, INC. (LFCR) reported Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent of 50.00% for the 12-month period ending 2025-05-25, per its 10-K filed 2025-08-07.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent · last filed 2025-08-07
- LIFECORE BIOMEDICAL, INC. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2025 was 50.00%, a 0.00% change from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2024 was 50.00%, a 0.00% change from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2023 was 50.00%, a 0.00% change from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2022 was 50.00%, a 0.00% change from fiscal 2021.
| Period end | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 12 month |
|---|---|
| 2025-05-25 | 50.00% 10-K · filed 2025-08-07 |
| 2024-05-26 | 50.00% 10-K · filed 2024-08-26 |
| 2023-05-28 | 50.00% 10-K · filed 2024-03-20 |
| 2022-05-29 | 50.00% 10-K/A · filed 2023-03-16 |
| 2021-05-30 | 50.00% 10-K · filed 2021-07-29 |
| 2020-05-31 | 50.00% 10-K · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |